
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
This information is supplementary to the article “A Practical Approach to Modelling of Reversed-Phase Liquid Chromatographic Separations: Advantages, Principles, and Possible Pitfalls” that was published in the March 2018 LCGC Europe issue.
Determination of dwell volume
over 8 years ago
Analytica 2018over 8 years ago
A Compendium of GC Detection, Past and Presentover 8 years ago
Vol 31 No 3 LCGC Europe March 2018 Regular Issue PDF




